Cryosa Inc.
Developing novel treatments for patients with sleep disordered breathing.
Developing novel treatments for patients with sleep disordered breathing.
Cryosa Inc. is a biotechnology and healthcare startup founded in 2018 with the slogan "Developing novel treatments for patients with sleep disordered breathing." The company focuses on developing innovative treatments for individuals suffering from sleep-disordered breathing. In their latest funding round, Santé Ventures, Solas BioVentures, and HOYA CORPORATION invested a substantial $21.50M Series B in the company on 23 September 2021. With their headquarter in the United States, Cryosa Inc. continues to make strides in the field of sleep-disordered breathing treatment, attracting significant support from prominent investors in the industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $21.50M | 3 |
|
23 Sep 2021 |
| Series A | $8.25M | 2 |
|
25 Jun 2020 |
| Series A | Unknown | 1 |
|
05 May 2020 |
| Series A | Unknown | 1 |
|
20 Apr 2018 |
No recent news or press coverage available for Cryosa Inc..
We care about your data, and we'd love to use cookies make your experience better.
